Clinical Trial Update: Flupentixol and Melitracen Tablets in the Treatment of Emotional Disorder [Phase 4]

View source ↗

Summary

Phase 4 trial update for flupentixol and melitracen tablets in emotional and neurologic disorders.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Emotional Disorder
• Neurologic Disorder

Drugs mentioned

• Flupentixol and melitracen tablets

Snippet

Sponsor: Peking University Third Hospital | Conditions: Emotional Disorder, Neurologic Disorder | Phase 4 | Status: COMPLETED